Arcturus Therapeutics Holdings Inc. (ARCT)
Nasdaq: ARCT · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Report filed | Mar 3, 2026 | Mar 6, 2025 | Mar 14, 2024 | Mar 29, 2023 | Mar 1, 2022 | Mar 1, 2021 | Mar 16, 2020 | · |
| Revenue | 82,031 | 152,310 | 166,799 | 205,999 | 12,359 | 9,539 | 20,789 | 15,753 |
| Research and development | 112,212 | 195,156 | 192,133 | 147,751 | 173,760 | 57,846 | 33,640 | 16,982 |
| General and administrative | 46,079 | 52,823 | 52,871 | 46,071 | 41,451 | 23,217 | 12,662 | 20,582 |
| Total operating expenses | 158,291 | 247,979 | 245,004 | 193,822 | 215,211 | 81,063 | 46,302 | 37,564 |
| Operating income | -76,260 | -95,669 | -78,205 | 12,177 | -202,852 | -71,524 | -25,513 | -21,811 |
| Share of profit of equity-method investments | · | · | · | -515 | 515 | -263 | -32 | -302 |
| Other income (expense), net | 10,095 | 15,195 | 16,591 | -420 | -1,921 | -361 | -446 | 328 |
| Income before income taxes | -65,783 | -80,945 | -27,890 | 10,644 | -203,674 | -72,148 | -25,991 | -21,785 |
| Income tax expense | · | -4 | 1,835 | 1,295 | · | · | · | · |
| Net income | -65,783 | -80,941 | -29,725 | 9,349 | -203,674 | -72,148 | -25,991 | -21,785 |
| Earnings per share, basic | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | · | · | · |
| Earnings per share, diluted | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -7.74 | -3.55 | -2.15 | -2.16 |
| Weighted average shares, basic | 27,386 | 27,000 | 26,628 | 26,445 | 26,317 | · | · | · |
| Weighted average shares, diluted | 27,386 | 27,000 | 26,628 | 27,093 | 26,317 | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 26,317 | 20,305 | 12,069 | 10,069 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted